Asthmatic Patients Clinical Trial
Official title:
Social-Economics Profile of the Asthmatic Patients Attended at Nucleus of Integrated Medical Care
Verified date | May 2008 |
Source | Fortaleza University |
Contact | n/a |
Is FDA regulated | No |
Health authority | Brazil: Ethics Committee |
Study type | Observational |
This study had a descriptive, retrospective, transversal character with quantitative approach, which aimed to delineate the social-economics profile of the asthmatic patients that used the health service available at the Care Nucleon Medical Integrate (NAMI)
Status | Completed |
Enrollment | 40 |
Est. completion date | June 2006 |
Est. primary completion date | May 2006 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 80 Years |
Eligibility |
Inclusion Criteria: - Patients enrolled in regular Nucleus of Integrated Medical Care; - Patients presented within the age group above to 80 years; - Patients accepted voluntarily join the search; - They used any medicine that received at the pharmacy of Nucleus of Integrated Medical Care. Exclusion Criteria: - Patients who don´t residing in the neighborhood of community; - Patients who don´t accepted part of the study by answering the questionnaire; - Have not made use of medicines in the last 60 days or have not received in the pharmacy of of Integrated Medical Care. |
Observational Model: Ecologic or Community, Time Perspective: Retrospective
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Fortaleza University |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00901368 -
FACTO Study (Foster® As Complete Treatment Option)
|
Phase 4 | |
Recruiting |
NCT01224977 -
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 4.
|
N/A | |
Terminated |
NCT01224964 -
Development and Validation of a Sputum Biomarker mRNA Panel for the Diagnostic Work-up of Asthma 3
|
N/A | |
Not yet recruiting |
NCT06385964 -
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SHR-4597 Inhalation in Healthy Subjects and Asthmatic Patients
|
Phase 1 |